Sleep Medicine DiSE: A 2-Drug Comparison and Simultaneous Polysomnography
Marina Carrasco, MD (presenter); Gabriela Agostini, MD; Adelaida Rodrigo, MD; Pau Giner, MD; Fernando Gómez, MD; Jose Dalmau, MD Objective: The aim of this study is to evaluate propofol and midazolam as sleep inducers in drug-induced sleep endoscopy, for the topographic diagnosis of upper airway obstruction during sleep; compare one to the other as well as with natural sleep polysomnography results.
Method: Prospective series of 16 patients with suspected obstructive sleep apnea. Following physical examination and conventional polysomnography, sleep nasendoscopy along with simultaneous polysomnography was performed, obtaining apnea-hypopnea index, lowest oxygen saturation, apnea durations, and sleep cycle stages. The procedure was done with propofol and with midazolam.
Results: There were 15 men and 1 woman; the mean age was 42.7 years old, mean body mass index 26.86. Average druginduced sleep endoscopy (DISE) duration was 20 minutes with propofol and 14.3 minutes with midazolam. The inducedsleep stage obtained was of phase 2. On 12 of the patients a whole-night polysomnography study was performed and compared with sleep nasendoscopy results. Physical exam did not correlate with drug-induced sleep findings. There was a good correlation between DISE results with both drugs (P < .001). The average apnea-hypopnea index was 16.38 for natural sleep, 28.63 for propofol, and 38.11 for midazolam.
Conclusion:
Obstruction areas are equivalent no matter which of the 2 mentioned sedatives are used. Although DISE is not entirely equivalent to an entire night sleep it can be considered comparable to most of the night sleep events.
Sleep Medicine Effects of Surgery on Quality of life in Obstructive Sleep Apnea Syndrome
Gultekin Kizilbulut, MD (presenter); Nebil Ark, MD; Kadriye S. Ugur, MD; Alper Yuksel, MD; Hanifi Kurtaran, MD; Mehmet Gunduz, MD Objective: To understand the influence of surgical treatment on quality of life and depression score in simple snorers and in mild, moderate, severe obstructive sleep apnea syndrome (OSAS) patients.
Method: This prospective cohort study involved 65 patients who underwent surgery with the diagnosis of simple snoring and OSAS between years 2007-2011. Short-form health survey (SF-36) and Beck Depression Inventory were used before and 18 months following surgery together with nocturnal polysomnography. Kruskal-Wallis test was used for statistical analysis.
Results: There was a statistically significant difference in apnea-hypopnea indexes (AHI) of moderate and severe apnea groups following surgery (P < .001). There was an increase in general health level of SF36 in mild apnea group (P = .009). There were increases in general health level and vitality level of SF36 in the moderate apnea group (P < .001). There was no difference among groups in Beck Depression Inventory scores postoperatively (P > .0125).
Conclusion:
Despite the favorable differences in apnea-hypopnea index scores, there is a limited favorable effect of surgical treatment on quality of life scores and no influence on depression scores in simple snorers and OSAS patients.
Sleep Medicine Extra-Esophageal Reflux (EER) and Sleep Disorders
Supawan Laohasiriwong, MD (presenter); B. Tucker Woodson, MD; Nikki Johnston, PhD
Objective: GERD is associated with sleep disorders, but how other reflux related disorders affect sleep is unknown. This study's goal is to evaluate the interaction of extra-esophageal reflux (EER) using subjective and objective (salivary pepsin) measures and sleep disorders including insomnia, hypersomnia, and sleep disordered breathing (SDB).
Method:
A prospective cohort of sleep and non-sleep adult patients were evaluated for insomnia, hypersomnia, SDB, sleep quality of life, nasal symptoms, and EER using validated questionnaires (PSQI, ESS, STOP BANG, FOSQ10 RSI, NOSE). Simultaneous pharyngeal saliva samples obtained in clinic underwent Western blot immunoassay for pepsin.
Results: Prevalence of pepsin (+) and elevated Reflux Symptom Index (RSI) in 70 adult subjects (54 assay complete) was 26% and 46.3%, respectively. Significant heartburn symptoms were reported in 14.8%. Pepsin (+) was not associated with any measure of sleep or non-sleep outcomes (P > .05). In contrast, a significant correlation (P < .001) was observed between RSI and insomnia (r = 0.47), sleep QOL (r = 0.45), and nasal symptoms (0.54) but not SDB (r = 0.03, ns). Nasal symptoms were strongly correlated with sleep disorders (r = 0.54, P < .001).
Conclusion:
Despite a low prevalence of GER in this population, a strong association between measures of EER and multiple measures of sleep quality as well as nasal obstruction was observed. Findings support that patient symptoms related to EER are associated with sleep disorders and sleep quality independent of GER.
